Q-omics provides the consensus-scored NDUFC2-KCTD14 profile across patient tissues and cancer cell-line models. Additionally, NDUFC2-KCTD14 RNA expression shows 443 significant gene co-expression associations, with the highest sampling consensus in SCLC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for NDUFC2-KCTD14 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with NDUFC2-KCTD14 in patient tissues and cancer cell lines. In patient samples, NDUFC2-KCTD14 shows the broadest associations at the RNA and protein expression levels, with SCLC recurring as the lineage with the largest associated feature set. In cancer cell lines, NDUFC2-KCTD14 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Lymphoma, while CRISPR and shRNA rows add functional-dependency signals in LUNG_SCLC.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	443	SCLC (443)	view →
Protein (mass-spec)	157	BRCA (92)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
RNA	1,799	BLOOD_Lymphoma (341)	view →
shRNA	1,662	LUNG_SCLC (166)	view →